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Risk factors for psychiatric disorders have traditionally been classified as genetic or environmental. 
Risk (candidate) genes, although typically possessing small effects, represent a clear starting 
point to elucidate downstream cellular/molecular pathways of disease. Environmental effects, 
especially during development, can also lead to altered behavior and increased risk for disease. 
An important environmental factor is the mother, demonstrated by the negative effects elicited 
by maternal gestational stress and altered maternal care. These maternal effects can also 
have a genetic basis (e.g., maternal genetic variability and mutations). The focus of this review 
is “maternal genotype effects” that influence the emotional development of the offspring 
resulting in life-long psychiatric disease-like phenotypes. We have recently found that genetic 
inactivation of the serotonin 1A receptor (5-HT1AR) and the fmr1 gene (encoding the fragile X 
mental retardation protein) in mouse dams results in psychiatric disease-like phenotypes in their 
genetically unaffected offspring. 5-HT1AR deficiency in dams results in anxiety and increased 
stress responsiveness in their offspring. Offspring of 5-HT1AR deficient dams display altered 
development of the hippocampus, which could be linked to their anxiety-like phenotype. Maternal 
inactivation of fmr1, like its inactivation in the offspring, results in a hyperactivity-like condition 
and is associated with receptor alterations in the striatum.  These data indicate a high sensitivity 
of the offspring to maternal mutations and suggest that maternal genotype effects can increase 
the impact of genetic risk factors in a population by increasing the risk of the genetically normal 
offspring as well as by enhancing the effects of offspring mutations.
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suggesting that a change in enzyme activity in mothers during preg-
nancy may be related to the increased likelihood of autism in their 
children. By using a similar approach, maternal (but not offspring 
or paternal) TPH1 (tryptophan hydroxylase) mutations have been 
shown to increase the risk for ADHD (Halmoy et al., 2011). There are 
additional examples supporting the effect of maternal mutations on 
gestational development, but they are all based on statistical data from 
relatively small populations that will need to be replicated (Johnson, 
2003). On the other hand, the list of maternal genes that affect off-
spring development could be expanded to include those that have an 
effect on maternal behavior prepartum and during early postnatal 
life. Experimental data in animals clearly show a significant impact 
of maternal care on the development of psychiatric disease-like con-
ditions (Meaney, 2001). Also, clinical studies indicate that maternal 
anxiety, depression, and ADHD increase the risk of psychopathol-
ogy (Halligan et al., 2004, 2007; Murray and Johnston, 2006; Davis 
and Tremont, 2007; Van den Bergh et al., 2008; Yehuda et al., 2008; 
Figueiredo and Costa, 2009; Brummelte and Galea, 2010; Murray 
et al., 2010). Although it is possible that these postnatal maternal 
effects may also have a genetic component, no maternal mutations 
have been identified in either human or animal models.
Since most association studies do not include the mother’s 
genotype, it is likely that the prevalence of maternal genotype 
effects is greatly underestimated in pedigrees and in   populations. 
Maternal genotype effects can contribute to the 
high heritability of psychiatric diseases
A large number of studies indicate that the pre/postnatal maternal 
environment can increase the offspring’s risk for psychopathology. 
Although some of these maternal effects may have a genetic basis 
or are at least influenced by genes, only a few examples of “maternal 
genotype effects” are currently known/confirmed in humans and 
in animal models (Doolin et al., 2002; Rouse and Azen, 2004). A 
classical example is maternal phenylketonuria (high blood pheny-
lalanine levels due to the lack of phenylalanine hydroxylase) that 
leads to mental retardation, seizures, microcephaly, and growth 
retardation in the offspring. Also, maternal mutations in methio-
nine biosynthesis (G allele of methionine synthase A2756G and 
methionine synthase reductase A66G polymorphisms) can lead to 
spina bifida in the offspring. Reports also indicate that maternal 
genotype effects contribute not only to neurological disorders but 
also to common psychiatric conditions such as autism and attention 
deficit hyperactivity disorder (ADHD). Glutathione S-transferases 
(GST), a protective factor against reactive oxygen species, is expressed 
in multiple forms and polymorphic variants. Maternal transmis-
sion disequilibrium tests showed that the Val allele of the Ile105Val 
(A313G) polymorphism in GSTP1 (a pi class GST) is overtrans-
mitted to mothers of autistic children (Williams et al., 2007). The 
variation at position 105 affects thermostability and catalytic activity Frontiers in Psychiatry  | Child and Neurodevelopmental Psychiatry    May 2011  | Volume 2  | Article 25  |  2
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Maternal serotonin 1a receptor and offspring anxiety
The serotonin (5-HT1A) receptor has been implicated in anxiety 
and depression through receptor binding and pharmacological 
studies (Drevets et al., 1999; Lemonde et al., 2003; Strobel et al., 
2003; Neumeister et al., 2004). The 5-HT1A receptor knockout 
mouse model demonstrates increased anxiety-related behavior in 
several behavioral assays, on multiple genetic backgrounds (Heisler 
et al., 1998; Parks et al., 1998; Ramboz et al., 1998). However, the 
interpretation of the anxiety phenotype of 5-HT1A receptor KO 
mice is complicated by the fact that following a typical heterozy-
gote × heterozygote (H × H) breeding, the offspring is exposed to a 
receptor deficient maternal environment. Considering the associa-
tion between the 5-HT1A receptor and depression (Van den Hove 
et al., 2006; Spinelli et al., 2010), including postpartum depression 
(Moses-Kolko et al., 2008), and the importance of maternal care on 
the normal emotional development of the offspring, the maternal 
receptor genotype itself may modulate anxiety-like behavior in 
the WT offspring and/or could interact with the null allele in the 
KO offspring, making the dissociation between the maternal and 
offspring genotype effects on offspring anxiety levels difficult. By 
studying maternal–offspring 5-HT1A receptor genotype interac-
tions, Weller et al. (2003) found reduced adult anxiety when the 
behavior of the H offspring of KO dams were compared to that of 
the WT dams suggesting an anxiolytic-like effect of the maternal 
KO alleles on offspring behavior. Since the offspring themselves 
were receptor deficient, the effect of maternal receptor deficiency 
as a single factor on offspring behavior could not be determined.
We recently showed that partial or complete 5-HT1A receptor defi-
ciency in Swiss Webster (SW) mouse dams can cause increased anxi-
ety-related behavior and enhanced stress reactivity in their offspring, 
independently of offspring genotype (Gleason et al., 2010; Figure 1) 
Genetically WT offspring of 5-HT1A receptor deficient mice displayed 
increased anxiety-related behavior in the elevated plus maze. This 
phenotype was found to require prenatal maternal 5-HT1A receptor 
deficiency, as mice which developed from WT embryos implanted into 
5-HT1A receptor deficient mothers and raised by either 5-HT1A defi-
cient or WT mothers after birth displayed increased anxiety-related 
behavior (Figure 1). This phenotype was also shown to be dependent 
on strain background (Gleason et al., 2010). In contrast, increased 
anxiety-related behavior in the open field, a less stressful assay for 
unconditioned anxiety, was found to be dependent on offspring 
5-HT1A receptor genotype. Finally, we demonstrated that maternal 
5-HT1A receptor deficiency leads to reduced immobility time in the 
Porsolt Forced Swim Test, which can be interpreted as a lack of normal 
coping skills and an increase in reactivity to inescapable stress. The 
development of this phenotype is independent of offspring genotype 
and requires both prenatal and postnatal maternal receptor deficit, as 
shown by embryo transfer and cross-fostering experiments.
In addition, we examined early postnatal development of the ven-
tral dentate gyrus of the hippocampus in mice exposed to maternal 
5-HT1A receptor deficiency, because the ventral hippocampus and 
this time period have been linked to the development of anxiety 
(Gross et al., 2002; Bannerman et al., 2003). We identified several 
developmental changes that correlate with later life anxiety-related 
behavior, including an increased volume of the ventral granule cell 
layer (GCL) during the first postnatal week, which normalized by 
the age of 4 weeks (in the absence of changes in the number of 
Indeed, maternal genotype effects could significantly contribute 
to the high heritability of common disorders including psy-
chiatric diseases. It is striking that despite the high heritability 
in these disorders (proportion of variability in a population 
attributable  to  genetic  variation  among  individuals),  only 
a small percentage of the risk can be explained by identified 
genetic variants, a phenomenon often referred to as missing 
heritability (Manolio et al., 2009). Since they are apparent at the 
pedigree and population level but not detectable at the genetic 
level, maternal genotype effects could be one of the mecha-
nisms that explain “missing heritability.” Therefore, maternal 
genotype effects may have major significance in understanding 
and treating common diseases, including psychiatric conditions 
discussed in this review.
aniMal Models can help identify MechanisMs 
underlying Maternal genotype effects
Although an altered prenatal environment due to maternal genetic 
variability has been shown as a risk factor in psychiatric diseases 
such as autism and ADHD (Williams et al., 2007; Halmoy et al., 
2011), the underlying disease mechanisms are difficult to identify 
because of the limitations associated with human studies. Animal 
(rodent) models have been invaluable tools in studying diseases, 
especially at the mechanistic level. Many rat and mouse lines are 
considered inbred – or lacking genetic differences between indi-
viduals – and therefore genetic mutations/modifications in the 
dams are not likely modified by between-subject genetic back-
ground variability. In addition to the highly controllable genetic 
background, rodent models allow for high degree of control of 
environmental  factors.  This  control  is  of  critical  importance 
because environmental influences could interfere with the mater-
nal genotype effect. Lastly, the advantages of rodent models include 
the availability of methods to determine if a particular behavioral 
change in the offspring is dependent on prenatal and/or postnatal 
parental or maternal environment. Cross-fostering, a procedure 
in which rodent pups are placed with a foster mother within the 
first postnatal day, can be used to determine whether a phenotype 
requires a postnatal maternal contribution, which may be either 
behavioral or physiological, transmitted through maternal milk. 
The advantages of animal models are clearly demonstrated in a 
work that explored the effect of a maternal mutation in Peg-3 
(paternally expressed gene 3). The maternal allele of this gene 
is imprinted and silenced and therefore the offspring of mutant 
mothers and wild-type (WT) fathers are essentially WT (expressing 
the paternal allele) allowing to study the maternal genotype effect 
without the interference of or interaction with the mutation in the 
offspring. The offspring of mutant mothers displayed increased 
neophobia and decreased exploration, although these effects were 
seen only in females (Champagne et al., 2009). Furthermore, an 
association was found between the offspring behavioral abnor-
malities and the reduced postpartum maternal care of Peg-3 KO 
dams (Curley et al., 2008).
To demonstrate the feasibility of mouse models in studying 
maternal genotype effects and their mechanisms, we present our 
research on two maternal mutations that alter specific behavioral 
phenotypes and correlated cellular or pharmacologic properties in 
the genetically unaffected offspring.www.frontiersin.org  May 2011  | Volume 2  | Article 25  |  3
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It is important to note that the offspring were more sensitive 
to the maternal than to their own receptor gene dosage as a par-
tial maternal receptor deficit was sufficient to elicit a full anxiety 
phenotype while a strong anxiety phenotype developed only in the 
homozygote knockout offspring (in the absence of maternal effect). 
The significance of this finding is that while a complete loss of the 
receptor has not been observed in humans, a 40–50% reduction in 
receptor binding, associated with stress and psychiatric disease, is 
relatively common (Lesch et al., 1992; Lopez et al., 1998; Drevets 
et al., 1999, 2007; Mann, 1999; Arango et al., 2001; Moses-Kolko 
et al., 2008). Therefore, a maternal 5-HT1AR deficit could be more 
relevant than an offspring deficit to human anxiety.
proliferating cells) and a maturational delay of developing neurons 
in the ventral GCL at postnatal day 7. To provide a possible link 
between the developmental delay in the ventral dentate gyrus and 
the maternal 5-HT1A receptor mediated anxiety-related behavior, 
we examined the effect of inactivating a candidate gene involved in 
neuronal precursor maturation, p16Ink4a. We found that deletion of 
this gene phenocopies both the ventral GCL volume increase in the 
first postnatal week, and the increased anxiety-related behavior in the 
elevated plus maze. These data indicate that the maternal 5-HT1A 
receptor deficit alters hippocampal development in the offspring, and 
that these developmental changes could contribute to the increased 
anxiety-like behavior in the elevated plus maze (Figure 2).
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Figure 1 | Diagram showing breeding and embryonic cross-fostering 
schemes for the 5-HT1A receptor deficient line. (A) WT mice are bred together 
to generate WT(WT) control animals with neither a maternal nor an offspring 
5-HT1A receptor effect. Homozygous 5-HT1A receptor knockout mice are bred 
together to generate KO(KO) mice with both a maternal and an offspring 5-HT1A 
receptor genotype effect, which display increased anxiety-related behavior in the 
elevated plus maze. WT and 5-HT1A receptor homozygous knockout mice are 
bred together to generate 5-HT1A receptor heterozygotes, which are 
intercrossed to generate both WT(H) and KO(H) mice, both of which also display 
increased anxiety-related behavior. WT(H) mice have a maternal but not offspring 
5-HT1A receptor genotype effect, while KO(H) mice have both a maternal and 
offspring 5-HT1A receptor genotype effect. (B) WT embryos (indicated by the 
oocyte in the donor) are implanted into WT and 5-HT1A receptor homozygous KO 
pseudopregnant mothers. Within 24 h after birth, pups are cross-fostered to WT 
or 5-HT1A receptor homozygous KO mothers, resulting in offspring raised with a 
prenatal, postnatal, or combined pre and postnatal maternal KO environment. 
Mice with either a prenatal or combined pre and postnatal maternal 5-HT1A 
receptor genotype effect exhibit increased anxiety-related behavior.Frontiers in Psychiatry  | Child and Neurodevelopmental Psychiatry    May 2011  | Volume 2  | Article 25  |  4
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tonic dopamine activity promoted by D2 autoreceptors and high 
phasic dopamine neurotransmission (Grace, 2001). Activation of 
D2 autoreceptors, by reducing the amount of DA released into the 
synapse (presynaptically) and reducing the excitability of the DA 
neurons (in the somatodendritic compartment), inhibits locomo-
tor activity in rodents (Starke et al., 1989; Cory-Slechta et al., 1996; 
Usiello et al., 2000; Figure 3). When we probed the dopamine sys-
tem using quinpirole at a D2 autoreceptor preferring dose, we found 
that the hyperactive offspring of FMRP deficient dams, regardless 
of their own genotype, had attenuated behavioral responses to 
quinpirole. This indicates a functional downregulation of the D2 
autoreceptor that can explain or contribute to the hyperactivity 
phenotype (Figure 4). While the functional D2 receptor downregu-
lation was not affected by the offspring genotype, the KO offspring 
of heterozygote fmr1 KO dams had a higher level of hyperactivity 
than their WT offspring indicating that only the maternally induced 
component of the hyperactivity may be explained by the downregu-
lation of presynaptic D2 receptors. In addition to the D2 autorecep-
tors, the presynaptic GABAB receptors also inhibit DA release while 
receptors located somatodendritically reduce the firing rate of DA 
neurons (Engberg et al., 1993; Smolders et al., 1995; Madden and 
Johnson, 1998; Labouebe et al., 2007; Figure 3). Administration of 
the GABAB agonist baclofen at doses that had no sedative effects 
resulted in a more prominent reduction in locomotor activity in the 
offspring of fmr1 heterozygote KO dams as compared to offspring 
of WT dams (Zupan and Toth, 2008b; Figure 4). Again, this change 
was maternal but not offspring genotype dependent. This indi-
cated a maternal genotype-dependent sensitization of the GABAB 
receptor in the offspring that may compensate for the hyperactivity 
related to the D2 receptor downregulation. Taken together, these 
data indicate that the maternal genotype effect can be linked not 
only to behavioral alterations but also to neurochemical changes 
which can ultimately help elucidate the underlying mechanisms.
Fmrp has been directly linked to FXS, as the sole cause of this 
Mendelian disorder. However, FMRP, at least in the mouse model, 
may have an additional function as its partial or complete deficit 
Maternal fragile x Mental retardation protein and 
offspring hyperactivity
Our second mouse model of human disease is produced by the inac-
tivation of the fmr1 gene encoding the fragile X mental retardation 
protein (FMRP). This model reproduces key behavioral features of 
the human fragile X syndrome (FXS; Consortium TD-BFX, 1994). 
FMRP is an RNA binding protein that affects multiple stages of 
RNA translation and is involved in the regulation of both local 
and global protein synthesis (Kao et al., 2010). Mice lacking Fmrp 
exhibit a number of FXS-like phenotypes including locomotor 
hyperactivity, sensory hyper-reactivity, cognitive defect, and mac-
roorchidism (D’Hooge et al., 1997; Peier et al., 2000; Chen and 
Toth, 2001; Spencer et al., 2005; Yun et al., 2006). In addition, Fmrp   
deficient mice reproduce some of the autistic-like behaviors seen 
in FXS. Interestingly, the manifestation of autistic-like behaviors 
is genetic background dependent, consistent with the observation 
that autistic behaviors in FXS vary considerably, presumably as a 
result of genetic modifiers (Spencer et al., 2011).
Although FMRP has been identified as the singular cause of 
FXS, a typical Mendelian disease, we found that the maternal Fmrp   
deficit can contribute to the development of some of the disease-
associated phenotypes. Specifically, we found that the genetically 
unaffected adult male offspring of heterozygote fmr1 KO dams 
displayed increased constitutive locomotor activity and that the 
combination of maternal and offspring genotype effects in the FXS 
mouse model had an additive effect on locomotor activity (Zupan 
and Toth, 2008a). This finding suggests that even a partial deficit in 
Fmrp  in the dam has long-term effects on offspring behavior and is 
sufficient to induce a disease-like phenotype. Other FXS-associated 
phenotypes such as macroorchidism and sensory hypersensitivity 
were unaffected by the maternal genotype and present only if fmr1 
was mutated in the offspring.
Locomotor activity is regulated in part by the activity of mes-
olimbic dopamine neurons originating in the ventral tegmental 
area and projecting to the ventral striatum (Koob and Swerdlow, 
1988; Szczypka et al., 2001). Hyperactivity has been linked to low 
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Figure 2 | Schematic showing how prenatal maternal 5-HT1A receptor 
deficiency may lead to alterations in offspring hippocampal development 
and increased anxiety-related behavior. 5-HT1A receptor deficiency in the 
mouse mother is signaled across the placenta during embryonic development 
and transmuted to the developing brain. This prenatal reprogramming results in 
delayed maturation in the early postnatal dentate gyrus, which may contribute to 
changes in hippocampal network formation and ultimately to increased 
anxiety-related behavior.www.frontiersin.org  May 2011  | Volume 2  | Article 25  |  5
Gleason et al.  Maternal mutations in psychiatric disease
First we discuss maternal genotype effects which are likely mediated 
by the behavioral interaction between mother and infant. Then we 
will discuss potential mediators of the maternal genotype effect that 
act during prenatal but also postnatal life.
influence of Maternal care and behavior on the offspring
Several genes have been identified as being required for normal 
maternal care, and mutations in these genes lead to phenotypes 
including impaired pup retrieval, failure of pups to thrive, and 
increased pup mortality. Some of these maternal mutations lead 
to severe impairment of maternal behavior and subsequent reduc-
tions in pup survival or impaired somatic development, and thus 
are not directly relevant to maternal genotype related psychiatric 
conditions. Nevertheless, we briefly summarize these genes below 
because they could provide insights to mother–infant interaction 
mechanisms. FosB null mouse dams exhibit impaired nurturing 
behavior (time crouching over pups, failure to maintain pups in 
a huddle), and impaired pup retrieval (Brown et al., 1996; Kuroda 
et al., 2008). CREBαδ null mouse dams also exhibit impaired 
pup retrieval, and CREBαδ heterozygous pups fail to thrive (Jin 
et al., 2005). Dams carrying a null allele of Peg-3 show reduced 
nurturing behavior toward their offspring and associated reduc-
tions in offspring survival, as well as reduced lactation, which 
was correlated with a reduction in the number of oxytocin neu-
rons in the hypothalamus (Li et al., 1999). In a follow-up study, 
Curley et al. (2004, 2008) examined the effect of Peg-3 mater-
nal and/or offspring deficiency on offspring development, and 
demonstrated that pups born to WT mothers who inherited a 
mutant Peg-3 allele exhibit reduced suckling activity and weight 
gain, and that their mothers ate less during pregnancy, indicating 
impaired fetal–maternal signaling. Peg-3 mutant mothers of WT 
pups also failed to increase caloric intake during pregnancy and 
had reduced milk let-down, while their offspring gained weight 
less rapidly and entered puberty later. When both mother and pup 
Striatum Midbrain
Figure 3 | illustration of dopamine D2 autoreceptors (orange) and 
gABAB receptors (green) on somatodendritic and presynaptic sites of a 
mesolimbic dopamine neuron. Maternal fmr1 insufficiency resulted in 
reduced D2 autoreceptor and enhanced GABAB receptor function in adult 
male offspring as measured by the locomotor response following quinpirole 
and baclofen administration, respectively.
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Figure 4 | Maternal and offspring fmr1 genotype effects on locomotor 
activity. Locomotor activity is increased in genetically unaffected animals due 
to maternal FMRP deficit, and this behavioral effect is further enhanced by the 
offspring’s own lack of FMRP . Maternal FMRP deficit increases GABAB 
receptor and decreases D2 autoreceptor function and this effect is not further 
modified by the offspring’s own fmr1 expression suggesting that these 
neurochemical changes are specifically associated with the maternal deficit 
in FMRP .
in the mother results in hyperactivity in the offspring that can be 
further increased by the offspring’s own mutation. This raises the 
possibility that in affected sons of mothers with full fmr1 mutation 
some of the behavioral phenotypes may be caused by a non-genetic 
mechanism related to the mother’s mutation and that genetically 
non-affected sons may also acquire some vulnerability to mental 
disorder. Interestingly, FMRP levels were found to be reduced in 
conditions unrelated to FXS such as autism, schizophrenia, bipolar 
disorder, and major depressive disorder (Fatemi and Folsom, 2011; 
Fatemi et al., 2010). Because the offspring are highly sensitive to 
even a partial reduction in FMRP, we speculate that these non-FXS 
conditions, via maternal effects, can expand the impact of FMRP 
in the human population.
possible Mediators of Maternal genotype effects
Maternal effects, unrelated to the genetic transfer of any genetic vari-
ation or mutation, are in principle either behavioral, in particular 
during the postnatal period, or are related to maternal substances that 
reach or signal to the developing brain during pre and/or postnatal life. Frontiers in Psychiatry  | Child and Neurodevelopmental Psychiatry    May 2011  | Volume 2  | Article 25  |  6
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field, and MWM behavior were shown to be no different from that 
of B6 mice raised by B6 mothers (Francis et al., 2003). Carola et al. 
(2008) used the maternal care variability in this strains to create 
mice that are genetically identical (B6/BalbC heterozygotes), but 
nonetheless display different maternal behavior based on maternal 
strain. They then utilized B6/BalbC heterozygote dams with either 
B6 or BalbC like behavior to study the effect of maternal behavior 
on offspring behavior. These data, although revealing no maternal 
genes, again indicate the importance of the maternal genotype on 
the behavior of genetically unrelated offspring producing psychi-
atric disease-like conditions.
Maternal cytokines
Maternal cytokines have been proposed as potential mediators 
that signal across the placenta to the developing embryo, either 
directly, or through induction of fetal cytokines. Although we have 
no direct evidence that the maternal genotype effects in the 5-HT1A 
receptor and Fmrp deficient mouse lines or in other models of 
maternal genotype effects would be mediated by cytokines, these 
molecules are plausible candidates because they can cross the pla-
centa and blood–brain barrier and because cytokine receptors are 
abundant in the brain, providing a means to convey the maternal 
genotype effects to developing neurons. Both the 5-HT1A recep-
tor and FMRP are expressed in immune cells and could alter their 
functions, including cytokine production and secretion. Indeed, the 
5-HT1A receptor is prominently expressed in the immune system 
and we and others have shown that 5-HT, via the 5-HT1A receptor, 
has chemotactic activity for eosinophils and mast cells (Boehme 
et al., 2004; Kushnir-Sukhov et al., 2006). Regarding FMRP, sig-
nificant differences in the plasma levels of a number of cytokines, 
including IL-1alpha, were reported between FXS individuals and 
controls (Ashwood et al., 2011).
The evidence for the ability of cytokines to alter offspring brain 
development and function comes from studies in which the mater-
nal immune system is challenged, resulting in offspring behavioral 
abnormalities (Smith et al., 2007; Patterson, 2009). Maternal infec-
tion and inflammation during pregnancy have long been implicated 
as potential predisposing factors to offspring psychiatric disorders, 
including schizophrenia and autism. For instance, retrospective 
studies  examining  maternal  medical  records  have  shown  that 
maternal infection increases the risk of schizophrenia in offspring 
(2× for respiratory infection, 8× for influenza infection; Brown 
et al., 1996; Byrne et al., 2007). Schizophrenia in offspring has also 
been associated with elevated cytokines and anti-influenza antibod-
ies in archived maternal serum (Brown et al., 2004a,b). A Danish 
registry study recently showed that maternal hospital admission due 
to either viral infection in the first trimester or bacterial infection 
in the second trimester was significantly associated with the diag-
nosis of Autism Spectrum Disorder in offspring (Atladottir et al., 
2010). Animal models that have been used to test the link between 
maternal inflammation and offspring psychiatric-like phenotypes 
include administration of lipopolysaccharide (LPS), polyinosinic 
polycytidylic acid [Poly(I:C)] or antibodies, or direct exposure 
to pathogens such as influenza, all of which induce an immune 
response in the dam, which may directly or via the induction of 
fetal cytokines have profound consequences for the developing fetus 
(reviewed in Boksa, 2010).
were mutant for Peg-3, these abnormalities were additive, and led 
to substantially increased pup mortality. Other genes implicated 
in maternal behavior include Mest/Peg1 (Lefebvre et al., 1998), 
the prolactin receptor gene (Lucas et al., 1998), the corticotropin-
releasing factor I gene (Gammie et al., 2007), Pet-1, encoding a 
serotonergic transcription factor (Lerch-Haner et al., 2008), the 
brain vasopressin gene (Bosch and Neumann, 2008), the oxytocin 
and the oxytocin receptor genes (Takayanagi et al., 2005), and 
CD38 (Jin et al., 2007).
As discussed earlier, thus far there have been few animal models 
in which specific maternal mutations were found to contribute to 
offspring behavioral changes that are reminiscent of psychiatric-
like conditions. Instead, research has focused mostly on strain 
differences, innate variability within rodent strains, or rodents 
selectively bred for behavioral traits. For instance, there is a line 
of Wistar rats selectively bred for anxiety (high anxiety behavior 
and low anxiety behavior rats; Liebsch et al., 1998), in which high 
anxiety rats have been shown to display reduced levels of maternal 
behavior relative to low anxiety rats (Kessler et al., 2011). However, 
these rat lines are bred to maximize phenotypic variability, and as 
such have a large number of genetic differences, making it difficult 
to determine which genetic changes are relevant to the observed 
behavioral changes.
Meaney and colleagues have compiled an extensive body of 
work demonstrating how innate variability in maternal behavior 
in Long–Evans rats can lead to altered offspring behavior. A large 
cohort of rats was phenotyped for natural variations in maternal 
behavior, and two subpopulations were identified, the 10% display-
ing the most licking–grooming and arched back nursing (High LG–
ABN), as well as the 10% displaying the lowest frequency of these 
behaviors (Low LG–ABN; Liu et al., 1997). The offspring of high 
LG–ABN rats were found to display reduced fearfulness, reduced 
hypothalamic–pituitary–adrenal (HPA) axis responses to stress, 
and decreased startle response, as well as increased hippocampal 
glucocorticoid receptor expression. When rats were cross-fostered 
at birth, their adult behavioral phenotypes and their own mater-
nal behavior resembled that of their foster mothers, indicating a 
postnatal and transgenerational effect (Francis et al., 1999). Again, 
the selection procedure segregated two different populations that 
likely differ in multiple genetic mutations or polymorphisms. The 
variability in maternal behavior was found to selectively alter the 
epigenome of the offspring by differential methylation of the glu-
cocorticoid receptor promoter during the first postnatal week, an 
effect which persisted into adulthood and was reversible through 
cross-fostering (Weaver et al., 2004). The group differences in epi-
genetic modification, glucocorticoid receptor expression, and HPA 
responses to stress could be removed through central infusion of 
a histone deacetylase inhibitor into the adult offspring (Weaver 
et al., 2004).
A similar approach was also used with mouse strains showing 
genetic and phenotypic heterogeneity. For instance, the C57/Bl6 
(B6) mouse displays greater licking/grooming behavior, reduced 
anxiety-related behavior, increased learning ability in the Morris 
water maze (MWM), and increased pre-pulse inhibition (PPI) of 
acoustic startle, relative to the BalbC. When BalbC zygotes were 
implanted into B6 hosts and raised by B6 foster mothers dams dur-
ing both the prenatal and postnatal period, elevated plus maze, open www.frontiersin.org  May 2011  | Volume 2  | Article 25  |  7
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effect presumably via the induction of fetal cytokines. Tuberous 
sclerosis (TSC) is a genetic condition in which 40–50% of affected 
individuals display autism spectrum disorder (Ehninger et al., 
2010). These authors exposed a mouse mutant for Tsc2 to gesta-
tional immune activation, and demonstrated that this mutation 
increases in utero mortality after Poly(I:C) injection, and that 
the combined genetic and environmental factors lead to abnor-
malities in social interaction in surviving offspring (Ehninger 
et al., 2010).
conclusion
The high heritability of psychiatric disorders is likely explained by 
a number of mechanisms including the inheritance of rare alleles 
with high penetrance and various combinations of low penetrance 
alleles. Here we describe another mechanism that could also signifi-
cantly contribute to the heritability of these disorders. Specifically, 
here we show that maternal mutations alone or in combination with 
offspring mutations can result in anxiety and hyperactivity in the 
offspring. The importance of maternal genotype effects is twofold. 
First, it can increase the severity of the phenotype caused by the 
offspring genotype. Second, maternal genotype effects can produce 
disease-like phenotypes in genetically unaffected individuals. This 
finding expands the population vulnerable to psychiatric disease. 
Since conventional association studies do not include the maternal 
genome, the identification of maternal genotype effects is difficult. 
Efforts to incorporate parental genomes into large scale genome-
wide association studies (Kong et al., 2009), could eventually help 
to estimate the overall impact of maternal genotypes in increasing 
risk for mental disorders.
Poly(I:C) is a synthetic dsRNA that acts through the toll-like 
receptor (TLR) 3 (Cunningham et al., 2007). The injection of 
Poly(I:C) into rodent dams during gestation has been shown to 
lead to a panoply of schizophrenia-related behavioral abnormali-
ties in their offspring including deficits in PPI, social interaction, 
latent inhibition, working memory, and novel object explora-
tion (Patterson, 2009). In addition, maternal Poly(I:C) exposure 
induces a range of histological and structural changes in systems 
relevant to schizophrenia, including increased GABAA receptor 
α2 immunoreactivity and dopamine hyperfunction, ventricular 
enlargement, reduced NMDA receptor expression in the hippoc-
ampus, and reduced dopamine D1 and D2 receptor expression 
in the prefrontal cortex (Patterson, 2009). These neurochemical 
changes may underlie the behavioral abnormalities. Extending 
the Poly(I:C) model of maternal immune activation, Abazyan 
et al. (2010) exposed an mhDISC1 mutant mouse to Poly(I:C) 
at gestational day 9 (GD9), which increased the anxiety-related 
behaviors, depression-like responses, and altered social behav-
iors in adults as compared to mutant mice of uninfected dams. 
Polymorphisms in the DISC1 gene have been linked to increased 
risk  of  several  psychiatric  diseases,  including  schizophrenia, 
major depression, bipolar disorder, autism, and Asperger’s syn-
drome (Millar et al., 2000, 2001; Blackwood et al., 2001; Kilpinen 
et al., 2008) and DISC1 mutant animals display a range of cellular 
and behavioral phenotypes relevant to schizophrenia (Clapcote 
et al., 2007; Hikida et al., 2007; Kvajo et al., 2008; Pletnikov et al., 
2008; Shen et al., 2008). Importantly, Poly(I:C) treatment altered 
cytokine levels in the fetal brain in a genotype-dependent manner 
indicating that offspring mutations can increase the maternal 
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